2019 China Ophthalmic Market Report: A Regional Analysis for 2018 to 2024, March, 2019
There are many new features in the 2019 version of this report, including:
Updated analysis of regulatory changes that will affect ophthalmology
Analysis of cataract surgery opportunity on a province-by-province basis
Profiles of seven eye hospital systems
Analysis of changes in China's refractive market
New glaucoma treatments on the market
Analysis of changes in the anti-VEGF market for retinal disease
Updated analysis of dry eye treatments
The 2019 China Ophthalmic Market Report is the leading industry source for accurate and relevant information on all aspects of the Chinese ophthalmic market. Our report includes a comprehensive overview of the Chinese population and economic conditions. We cover prevalence of and forecasts for eye diseases and conditions and discuss therapeutic approaches, including commercialized and pipeine products. We analyze unit demand and revenues and forecast future performance over the next five years. We also include market share data and discuss key strategic issues.
2 licensing types are available for this report:
The price of the report is $6,750 for a single-user license.
The price of the enterprise license is $10,125 (includes supplemental Excel file with all the tables and figures in the report).
Both licenses include an electronic PDF. Printed copies may be purchased for an additional $250.
SINGLE USER LICENSE
The Single User License allows for the use of a report by a single user within one corporate location.
The report paper copy may not be reproduced (additional paper copies available for purchase).
Report PDF copy can not be copied (if purchased) and must remain on one computer (not a company server).
Only a single copy of the publication may be printed for internal use.
Users may include information in the report in presentations and internal reports by providing full copyright credit to Market Scope.
Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.
The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.
Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.
Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Market Scope.
Purchase price includes both a paper copy and printable PDF file of the report. (purchasing organization may print multiple copies for use within the organization)
Purchase price includes a supplemental Excel file containing all the tables and figures included in the purchased report.
Peter Downs has more than 30 years of experience as a business and medical journalist and investigative reporter. He has written for a variety of medical industry publications, including the Medical Business Journal, CBS HealthWatch, and Oncology News International.
Prior to joining Market Scope in 2015 and turning his attention to ophthalmology, Peter analyzed markets for organ and tissue transplantation. Since joining Market Scope, he has traveled to several markets outside the US, including China, Europe, and India, to study ophthalmology at the local level.
In addition to his research and writing efforts on the ophthalmic market, he is also a contributor to Ophthalmic Market Perspectives, the firm’s monthly industry.
Want to Purchase the Full Report?
Already Have an Account?
Register A Corporate Account
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.